哈羅公司
US ˙ NasdaqGM ˙ US4158581094

SecurityHROW / Harrow, Inc.
InstitutionVanguard Group Inc
Latest Disclosed Ownership0 shares
Ownership 0.00%
Vanguard Group Inc ownership in HROW / Harrow, Inc.

2026-03-27 - Vanguard Group Inc has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Harrow, Inc. (US:HROW). This represents 0.0 percent ownership of the company. In their previous filing dated 2024-02-13 , Vanguard Group Inc had reported owning 1,808,552 shares, indicating a decrease of -100.00 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date		Effective
Date		Form Prev
Shares		 Latest
Shares		 ΔShares
(Percent)		 Ownership
(Percent)		 ΔOwnership
(Percent)
2026-03-27 2026-03-27 13G/A 1,808,552 0 -100.00 0.00 -100.00
2024-02-13 2024-02-13 13G 1,808,552 5.15

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-01-29 2025-12-31 13F HARROW COM 415858109 1,921,683 50,889 2.72 94,162 4.47 0.0014
2025-11-07 2025-09-30 13F HARROW COM 415858109 1,870,794 1,534 0.08 90,135 57.89 0.0013
2025-08-11 2025-06-30 13F HARROW COM 415858109 1,869,260 3,811 0.20 57,087 15.05 0.0009
2025-05-09 2025-03-31 13F HARROW COM 415858109 1,865,449 -6,651 -0.36 49,621 -21.00 0.0009
2025-02-11 2024-12-31 13F HARROW COM 415858109 1,872,100 5,225 0.28 62,809 -25.17 0.0011
2024-11-13 2024-09-30 13F HARROW COM 415858109 1,866,875 26,165 1.42 83,935 118.28 0.0015
2024-08-13 2024-06-30 13F HARROW COM 415858109 1,840,710 10,905 0.60 38,452 58.84 0.0007
2024-05-10 2024-03-31 13F HARROW COM 415858109 1,829,805 21,253 1.18 24,208 19.52 0.0005
2024-03-11 2023-12-31 13F/A-1 HARROW COM 415858109 1,808,552 48,673 2.77 20,256 -19.91 0.0004
2024-02-14 2023-12-31 13F HARROW COM 415858109 1,808,552 48,673 20,256 0.0004
2023-12-18 2023-09-30 13F/A-1 HARROW COM 415858109 1,759,879 95,389 5.73 25,289 -20.20 0.0006
2023-11-14 2023-09-30 13F HARROW COM 415858109 1,759,879 95,389 25,289 0.0001
2023-08-14 2023-06-30 13F HARROW HEALTH COM 415858109 1,664,490 278,164 20.06 31,692 8.04 0.0008
2023-07-14 2023-03-31 13F/A-1 HARROW HEALTH COM 415858109 1,386,326 213,530 18.21 29,335 69.46 0.0007
2023-05-15 2023-03-31 13F HARROW HEALTH COM 415858109 1,386,326 213,530 29,335 0.0002
2023-02-10 2022-12-31 13F HARROW HEALTH COM 415858109 1,172,796 -7,810 -0.66 17,310 21.47 0.0005
2022-11-14 2022-09-30 13F HARROW HEALTH COM 415858109 1,180,606 0 0.00 14,250 65.81 0.0004
2022-08-12 2022-06-30 13F HARROW HEALTH COM 415858109 1,180,606 102,525 9.51 8,594 16.88 0.0002
2022-05-13 2022-03-31 13F HARROW HEALTH COM 415858109 1,078,081 -6,978 -0.64 7,353 -21.57 0.0002
2022-02-14 2021-12-31 13F HARROW HEALTH COM 415858109 1,085,059 -1,475 -0.14 9,375 -5.07 0.0002
2021-11-12 2021-09-30 13F HARROW HEALTH COM 415858109 1,086,534 0 0.00 9,876 -2.16 0.0002
2021-08-13 2021-06-30 13F HARROW HEALTH COM 415858109 1,086,534 -201,573 -15.65 10,094 16.09 0.0003
2021-05-14 2021-03-31 13F HARROW HEALTH COM 415858109 1,288,107 34,972 2.79 8,695 1.15 0.0002
2021-02-12 2020-12-31 13F HARROW HEALTH COM 415858109 1,253,135 15,691 1.27 8,596 24.27 0.0002
2020-11-16 2020-09-30 13F HARROW HEALTH COM 415858109 1,237,444 -7,028 -0.56 6,917 6.69 0.0002
2020-08-14 2020-06-30 13F HARROW HEALTH COM 415858109 1,244,472 105,963 9.31 6,483 49.03 0.0002
2020-05-15 2020-03-31 13F HARROW HEALTH COM 415858109 1,138,509 4,200 0.37 4,350 -50.71 0.0002
2020-02-14 2019-12-31 13F HARROW HEALTH COM 415858109 1,134,309 0 0.00 8,825 38.43 0.0003
2019-11-14 2019-09-30 13F HARROW HEALTH COM 415858109 1,134,309 16,029 1.43 6,375 -34.47 0.0002
2019-08-14 2019-06-30 13F HARROW HEALTH COM 415858109 1,118,280 9,112 0.82 9,729 76.12 0.0004
2019-05-15 2019-03-31 13F HARROW HEALTH COM 415858109 1,109,168 212,288 23.67 5,524 8.25 0.0002
2019-02-14 2018-12-31 13F IMPRIMIS PHARMACEUTICALS COM 45323A201 896,880 166,489 22.79 5,103 151.26 0.0002
2018-12-13 2018-09-30 13F/A-2 IMPRIMIS PHARMACEUTICALS COM NEW 45323A201 730,391 19,100 2.69 2,031 29.78 0.0001
2018-11-23 2018-09-30 13F/A-1 IMPRIMIS PHARMACEUTICALS COM NEW 45323A201 730,391 0 2,031 0.0001
2018-11-14 2018-09-30 13F IMPRIMIS PHARMACEUTICALS COM NEW 45323A201 730,391 19,100 2,031
2018-08-14 2018-06-30 13F IMPRIMIS PHARMACEUTICALS COM NEW 45323A201 711,291 31,925 4.70 1,565 30.85 0.0001
2018-05-15 2018-03-31 13F IMPRIMIS PHARMACEUTICALS COM NEW 45323A201 679,366 15,796 2.38 1,196 6.03 0.0001
2018-02-14 2017-12-31 13F IMPRIMIS PHARMACEUTICALS COM NEW 45323A201 663,570 161,703 32.22 1,128 39.60 0.0000
2017-11-14 2017-09-30 13F IMPRIMIS PHARMACEUTICALS COM NEW 45323A201 501,867 50,641 11.22 808 -44.04 0.0000
2017-08-24 2017-06-30 13F/A-1 IMPRIMIS PHARMACEUTICALS COM NEW 45323A201 451,226 198,068 78.24 1,444 36.74 0.0001
2017-08-11 2017-06-30 13F IMPRIMIS PHARMACEUTICALS COM NEW 45323A201 451,226 198,068 1,444
2017-05-12 2017-03-31 13F IMPRIMIS PHARMACEUTICALS COM NEW 45323A201 253,158 48,286 23.57 1,056 106.25 0.0001
2017-02-14 2016-12-31 13F IMPRIMIS PHARMACEUTICALS COM NEW 45323A201 204,872 19,888 10.75 512 -27.38 0.0000
2016-11-14 2016-09-30 13F IMPRIMIS PHARMACEUTICALS COM NEW 45323A201 184,984 16,400 9.73 705 11.20 0.0000
2016-08-10 2016-06-30 13F IMPRIMIS PHARMACEUTICALS COM NEW 45323A201 168,584 2,831 1.71 634 -3.65 0.0000
2016-05-13 2016-03-31 13F IMPRIMIS PHARMACEUTICALS COM NEW 45323A201 165,753 8,387 5.33 658 -39.69 0.0000
2016-02-08 2015-12-31 13F IMPRIMIS PHARMACEUTICALS COM NEW 45323A201 157,366 64,500 69.45 1,091 82.14 0.0001
2015-11-12 2015-09-30 13F/A-1 IMPRIMIS PHARMACEUTICALS COM NEW 45323A201 92,866 2,900 3.22 599 -18.06 0.0000
2015-11-12 2015-09-30 13F/A-1 IMPRIMIS PHARMACEUTICALS COM NEW 45323A201 92,866 2,900 599 0.0000
2015-11-12 2015-09-30 13F IMPRIMIS PHARMACEUTICALS COM NEW 45323A201 4,285,063 129,134
2015-08-13 2015-06-30 13F IMPRIMIS PHARMACEUTICALS COM NEW 45323A201 89,966 2,296 2.62 731 4.58 0.0000
2015-05-15 2015-03-31 13F/A-1 IMPRIMIS PHARMACEUTICALS COM NEW 45323A201 87,670 0 0.00 699 6.23 0.0000
2015-05-14 2015-03-31 13F IMPRIMIS PHARMACEUTICALS COM NEW 45323A201 87,670 699
2015-02-12 2014-12-31 13F IMPRIMIS PHARMACEUTICALS COM NEW 45323A201 87,670 0 0.00 658 1.08 0.0000
2014-11-12 2014-09-30 13F IMPRIMIS PHARMACEUTICALS COM NEW 45323A201 87,670 1,297 1.50 651 8.50 0.0001
2014-08-11 2014-06-30 13F IMPRIMIS PHARMACEUTICALS COM NEW 45323A201 86,373 7,669 9.74 600 14.94 0.0000
2014-05-13 2014-03-31 13F IMPRIMIS PHARMACEUTICALS COM NEW 45323A201 78,704 15,604 24.73 522 147.39 0.0000
2014-02-12 2013-12-31 13F IMPRIMIS PHARMACEUTICALS COM NEW 45323A201 63,100 0 0.00 211 -29.19 0.0000
2013-11-07 2013-09-30 13F IMPRIMIS PHARMACEUTICALS COM NEW 45323A201 63,100 0 0.00 298 -44.30 0.0000
2013-08-13 2013-06-30 13F IMPRIMIS PHARMACEUTICALS COM NEW 45323A201 63,100 63,100 535 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.